The Recall Desk
LowFDA (Drugs)·D-200-2013·Announced 2013-03-20

Fresenius Kabi Recalls Calcium Glucosate Injection Due to Missing Label

Fresenius Kabi USA LLC is recalling 155,900 vials of Calcium Glucosate Injection, USP, 10% due to missing labels. The recall is nationwide.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The hazard is a documentation/packaging issue (missing label) rather than a direct safety defect.

Plain-English summary

Fresenius Kabi USA LLC (FK USA) is recalling 155,900 vials of Calcium Glucosate Injection, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial. The product is identified by Product Code 31110 and NDC 63323-311-10. The specific lot affected is 6004889, with an expiration date of 10/2014.

The recall was initiated because the vials are missing labels. This is a Class III recall, which indicates that the product is not likely to cause adverse health consequences.

The affected product was distributed nationwide. Healthcare providers and patients should stop using the affected vials and contact their supplier or the recalling firm for further instructions.

The recalled product

Product
CALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IV Additive Use Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- Product Code 31110, NDC 63323-311-10
Affected units
155,900

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot 6004889
  • Expiration Date 10/2014

Distribution

Distributed nationwide across the United States.

Same manufacturer · Fresenius Kabi USA LLC (FK USA)

See all →